What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

Q: Would you define scleroderma? What are the early symptoms? Are there any tests to diagnose it? A: Scleroderma, or hard skin, isn't a common disorder. In a metropolitan area the size of St. Louis, ...

UVA researcher Blandine Baffert, working in the lab of UVA Health’s Sanja Arandjelovic and collaborating with researchers in ...

Ask the Experts - Respiratory Failure in Dermatomyositis I have a female patient with recently diagnosed Jo-1 antibody-positive dermatomyositis (skin rash, creatine phosphokinase [CPK] >3000 U/L, nail ...

Jennene's swollen hands and feet during a bike ride were the first sign of scleroderma - a rare autoimmune condition.

NEW HAVEN, Conn. (WTNH) — June is Scleroderma Awareness Month, which draws attention to the autoimmune disease that leads to chronic hardening and tightening of connective tissues. Dr. Monique ...

Scleroderma, or systemic sclerosis refers to a disorder in which the skin and connective tissues of the body start to thicken and harden because of the overproduction of a protein called collagen.

WASHINGTON _ First Bari Martz's fingers turned blue. Then she started gasping for breath, and her joints stiffened so that she couldn't even open her hands. Doctors diagnosed scleroderma, part of an ...

The University of Michigan John Varga Lab, in collaboration with the Mayo Clinic and Northwestern researchers, published an article last year suggesting that a heavy-chain monoclonal antibody, Ab68, ...

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will ...

Indero is pleased to announce a strategic collaboration with the World Scleroderma Foundation (WSF) to support WSF SHIELD platform trial, a randomized, double-blind, adaptive platform clinical trial ...